We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sinclair Pha | LSE:SPH | London | Ordinary Share | GB0033856740 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 31.80 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMSPH
RNS Number : 2122G
Sinclair Pharma PLC
02 November 2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
2 November 2018
Sinclair Pharma plc
("Sinclair" or the "Company")
Rule 2.9 Announcement
In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at 08:00 am on 2 November 2018, it had 517,657,084 ordinary shares of 1 pence each in issue and admitted to trading on AIM. No ordinary shares are held in treasury. Accordingly, the total number of voting rights in Sinclair is 517,657,084. The International Securities Identification Number ("ISIN") for Sinclair's ordinary shares is GB0033856740.
For further information, please contact:
Hot Features
Premium
+44 (0) 20 7467
Sinclair Pharma plc 6920
Chris Spooner
Alan Olby
Andy Crane
+44 (0) 20 7280
Rothschild (Lead Financial Adviser to Sinclair) 5000
Dominic Hollamby
Julian Hudson
Josh Johnson
Peel Hunt LLP (Joint Financial Adviser, NOMAD +44 (0)20 7418
and Joint Broker to Sinclair) 8900
James Steel
Michael Nicholson
Oliver Jackson
+ 44 (0) 203
FTI Consulting (Public Relations Adviser to Sinclair) 727 1000
Ben Atwell
Brett Pollard
Stephanie Cuthbert
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
RTTBTBTTMBJMBIP
(END) Dow Jones Newswires
November 02, 2018 08:36 ET (12:36 GMT)
1 Year Sinclair Pharma Chart |
1 Month Sinclair Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
